Epigenetic hallmarks of cancer unveiled in new research

Eisai and Biogen’s Leqembi received accelerated approval from the US Food and Drug Administration (FDA) in January, which was converted into full approval earlier this

MAPS Pub­lic Ben­e­fit Cor­po­ra­tion is tout­ing an­oth­er set of promis­ing Phase III re­sults in­ves­ti­gat­ing its MD­MA-as­sist­ed ther­a­py for post-trau­mat­ic stress dis­or­der (PTSD), with the tri­al